ABRAXIS BIOSCIENCE, LLC

METHOD FOR TREATING CANCER BASED ON LEVEL OF GLUCOCORTICOID RECEPTOR

#2 | 2017-02-23 ✅ Patent 9,820,949 granted on 2017-11-21

US20170049711A1

Methods of treatment of pancreatic cancer

#3 | 2017-01-26 ✅ Patent 9,855,220 granted on 2018-01-02

US20170020824A1

Methods of treating pancreatic cancer

#4 | 2016-10-20 ✅ Patent 10,053,504 granted on 2018-08-21

US20160304592A1

SPARC binding ScFvs

#5 | 2016-06-09

US20160158365A9

METHODS AND COMPOSITIONS FOR TREATING RECURRENT CANCER

#6 | 2016-01-21

US20160015817A1

METHODS OF TREATMENT OF PEDIATRIC SOLID TUMOR

#7 | 2015-11-05 ✅ Patent 9,724,323 granted on 2017-08-08

US20150313866A1

Breast cancer therapy based on hormone receptor status with nanoparticles comprising taxane

#8 | 2015-06-11 ✅ Patent 9,585,960 granted on 2017-03-07

US20150157722A1

Use of polymeric excipients for lyophilization or freezing of particles

#9 | 2015-05-21 ✅ Patent 9,671,406 granted on 2017-06-06

US20150141343A1

SPARC and methods of use thereof

#10 | 2015-04-16

US20150104521A1

NOVEL FORMULATIONS OF PHARMACOLOGICAL AGENTS, METHODS FOR THE PREPARATION THEREOF AND METHODS FOR THE USE THEREOF

#11 | 2015-03-19

US20150079181A1

METHODS AND COMPOSITIONS FOR TREATING RECURRENT CANCER

#12 | 2014-12-18 ✅ Patent 9,295,733 granted on 2016-03-29

US20140370016A1

SPARC binding ScFcs

#13 | 2014-11-20 ✅ Patent 9,314,537 granted on 2016-04-19

US20140341905A1

SPARC binding ScFcs

#14 | 2014-10-09

US20140302157A1

NANOPARTICLE FORMULATIONS AND USES THEROF

#15 | 2014-10-02 ✅ Patent 9,446,003 granted on 2016-09-20

US20140296353A1

Prion free nanoparticle compositions and methods of making thereof

#16 | 2014-10-02 ✅ Patent 9,061,014 granted on 2015-06-23

US20140296279A1

Intravascular delivery of nanoparticle compositions and uses thereof

#17 | 2014-09-18

US20140271871A1

METHODS AND COMPOSITIONS FOR TREATING PULMONARY HYPERTENSION

#18 | 2014-07-17

US20140199404A1

METHOD FOR TREATING CANCER BASED ON LEVEL OF A NUCLEOSIDE TRANSPORTER

#19 | 2014-07-17 ✅ Patent 9,511,046 granted on 2016-12-06

US20140199403A1

Methods of treating pancreatic cancer

#20 | 2014-07-03

US20140186447A1

NANOPARTICLE COMPOSITIONS OF ALBUMIN AND PACLITAXEL

#21 | 2014-06-19

US20140170228A1

COMBINATION THERAPY METHODS FOR TREATING PROLIFERATIVE DISEASES

#22 | 2014-05-15 ✅ Patent 9,149,455 granted on 2015-10-06

US20140134257A1

Methods of treating melanoma

#23 | 2014-04-03

US20140094416A1

SPARC ANGIOGENIC DOMAIN AND METHODS OF USE

#24 | 2014-03-20

US20140080901A1

NANOPARTICLE FORMULATIONS AND USES THEREOF

#25 | 2014-03-20 ✅ Patent 9,561,288 granted on 2017-02-07

US20140079793A1

Combinations and modes of administration of therapeutic agents and combination therapy

#26 | 2014-03-20 ✅ Patent 9,399,072 granted on 2016-07-26

US20140079788A1

Methods of treatment of pancreatic cancer

#27 | 2014-03-20

US20140079787A1

METHODS FOR TREATING HEPATOCELLULAR CARCINOMA

#28 | 2014-03-13 ✅ Patent 9,597,409 granted on 2017-03-21

US20140072643A1

Methods of treating cancer

#29 | 2014-03-13

US20140072631A1

COMBINATIONS AND MODES OF ADMINISTRATION OF THERAPEUTIC AGENTS AND COMBINATION THERAPY

#30 | 2014-03-13

US20140072630A1

COMBINATION THERAPY WITH NANOPARTICLE COMPOSITIONS OF TAXANE AND HEDGEHOG INHIBITORS

#31 | 2014-02-27

US20140056986A1

METHODS OF TREATING BLADDER CANCER

#32 | 2014-02-06 ✅ Patent 9,012,519 granted on 2015-04-21

US20140039070A1

Compositions and methods of delivery of pharmacological agents

#33 | 2014-02-06 ✅ Patent 9,012,518 granted on 2015-04-21

US20140039069A1

Compositions and methods of delivery of pharmacological agents

#34 | 2014-01-23

US20140023717A1

METHODS AND COMPOSITIONS FOR TREATING PROLIFERATIVE DISEASES

#35 | 2014-01-16

US20140017323A1

METHODS OF ENHANCING DRUG DELIVERY AND EFFECTIVENESS OF THERAPEUTIC AGENTS

#36 | 2014-01-16

US20140017316A1

METHODS AND COMPOSITIONS FOR TREATING RECURRENT CANCER

#37 | 2014-01-16

US20140017315A1

METHODS AND COMPOSITIONS FOR TREEATING PROLIFERATIVE DISEASES

#38 | 2013-12-05

US20130323263A1

SPARC ANGIOGENIC DOMAIN AND METHODS OF USE

#39 | 2013-11-28 ✅ Patent 8,821,836 granted on 2014-09-02

US20130315823A1

SPARC binding peptides and uses thereof

#40 | 2013-10-24

US20130281376A1

SPARC MICROENVIRONMENT SIGNATURE, PLASMA SPARC, AND LDH AS PROGNOSTIC BIOMARKERS IN THE TREATMENT OF CANCER

#41 | 2013-10-24 ✅ Patent 8,999,396 granted on 2015-04-07

US20130280337A1

Breast cancer therapy based on hormone receptor status with nanoparticles comprising taxane

#42 | 2013-09-19 ✅ Patent 8,846,771 granted on 2014-09-30

US20130244952A1

Compositions and methods of delivery of pharmacological agents

#43 | 2013-08-15 ✅ Patent 9,101,543 granted on 2015-08-11

US20130209518A1

Combinations and modes of administration of therapeutic agents and combination therapy

#44 | 2013-08-08 ✅ Patent 9,399,071 granted on 2016-07-26

US20130202709A1

Methods of treatment of pancreatic cancer

#45 | 2013-08-01

US20130195984A1

COMBINATIONS AND MODES OF ADMINISTRATION OF THERAPEUTIC AGENTS AND COMBINATION THERAPY

#46 | 2013-08-01

US20130195922A1

METHODS AND COMPOSITIONS FOR TREATING PROLIFERATIVE DISEASES

#47 | 2013-08-01

US20130195757A1

SPARC BINDING APTAMERS AND USES THEREOF

#48 | 2013-07-11 ✅ Patent 8,916,204 granted on 2014-12-23

US20130178423A1

SPARC and methods of use thereof

#49 | 2013-07-11 ✅ Patent 8,946,169 granted on 2015-02-03

US20130178422A1

SPARC and methods of use thereof

#50 | 2013-07-04 ✅ Patent 9,091,697 granted on 2015-07-28

US20130172261A1

Use of 2 anti-SPARC antibodies to predict response to chemotherapy for pancreatic adenocarcinoma

#51 | 2013-05-09 ✅ Patent 9,370,494 granted on 2016-06-21

US20130115296A1

Methods for treating hepatocellular carcinoma

#52 | 2013-04-25 ✅ Patent 9,096,660 granted on 2015-08-04

US20130101504A1

SPARC binding antibodies and uses thereof

#53 | 2013-02-21

US20130045240A1

COMBINATION THERAPY WITH NANOPARTICLE COMPOSITIONS OF TAXANE AND HEDGEHOG INHIBITORS

#54 | 2012-12-06 ✅ Patent 9,308,180 granted on 2016-04-12

US20120308612A1

Compositions and methods for preparation of poorly water soluble drugs with increased stability

#55 | 2012-09-27

US20120245089A1

USE OF THE SPARC MICROENVIRONMENT SIGNATURE IN THE TREATMENT OF CANCER

#56 | 2012-07-19

US20120183538A1

SPARC ANTISENSE COMPOSITIONS AND USES THEREOF

#57 | 2012-07-12 ✅ Patent 8,268,348 granted on 2012-09-18

US20120177743A1

Combinations and modes of administration of therapeutic agents and combination therapy

#58 | 2012-04-12

US20120087910A1

SPARC ANGIOGENIC DOMAIN AND METHODS OF USE

#59 | 2012-03-22 ✅ Patent 9,393,318 granted on 2016-07-19

US20120070502A1

Methods of treating cancer

#60 | 2012-03-01

US20120052007A1

PERIPHERAL BLOOD SPARC BINDING ANTIBODIES AND USES THEREOF

#61 | 2012-02-16 ✅ Patent 8,445,637 granted on 2013-05-21

US20120039801A1

SPARC binding peptides and uses thereof

#62 | 2012-01-26 ✅ Patent 9,193,782 granted on 2015-11-24

US20120020959A1

Use of the SPARC microenvironment signature in the treatment of cancer

#63 | 2012-01-19 ✅ Patent 8,809,507 granted on 2014-08-19

US20120014954A1

SPARC binding ScFvs

#64 | 2012-01-12

US20120009123A1

Albumin binding peptide-mediated disease targeting

#65 | 2012-01-05 ✅ Patent 8,314,156 granted on 2012-11-20

US20120004177A1

Compositions and methods of delivery of pharmacological agents

#66 | 2011-12-08 ✅ Patent 8,138,229 granted on 2012-03-20

US20110301248A1

Compositions and methods of delivery of pharmacological agents

#67 | 2011-06-23 ✅ Patent 8,580,786 granted on 2013-11-12

US20110150763A1

Performing operations; transporting

Triazine derivatives and their therapeutical applications

#68 | 2011-03-31

US20110076456A1

LENS ARRAYS AND METHODS OF MAKING THE SAME

#69 | 2011-01-13

US20110009337A1

Q3 SPARC DELETION MUTANT AND USES THEREOF

#70 | 2010-12-09 ✅ Patent 8,383,358 granted on 2013-02-26

US20100310507A1

Use of 2 anti-SPARC antibodies to predict response to melanoma chemotherapy

#71 | 2010-12-02

US20100305148A1

DI-ESTER PRODRUGS OF CAMPTOTHECIN, PROCESS FOR THEIR PREPARATION AND THEIR THERAPEUTICAL APPLICATIONS

#72 | 2010-11-04

US20100279963A1

DICARBONYL DERIVATIVES AND METHODS OF USE

#73 | 2010-09-09 ✅ Patent 7,820,788 granted on 2010-10-26

US20100226996A1

Compositions and methods of delivery of pharmacological agents

#74 | 2010-08-26 ✅ Patent 8,927,019 granted on 2015-01-06

US20100215751A1

Methods and compositions for treating recurrent cancer

#75 | 2010-08-05 ✅ Patent 7,923,536 granted on 2011-04-12

US20100196490A1

Compositions and methods of delivery of pharmacological agents

#76 | 2010-07-22 ✅ Patent 8,911,786 granted on 2014-12-16

US20100183728A1

Nanoparticle comprising rapamycin and albumin as anticancer agent

#77 | 2010-06-24 ✅ Patent 8,026,275 granted on 2011-09-27

US20100160448A1

Compositions, methods of use and preparation of 2,6-diisopropyl phenol and analogs for ischemic injury

#78 | 2010-05-06

US20100112077A1

NANOPARTICLES OF PACLITAXEL AND ALBUMIN IN COMBINATION WITH BEVACIZUMAB AGAINST CANCER

#79 | 2010-02-25 ✅ Patent 9,675,578 granted on 2017-06-13

US20100048499A1

Breast cancer therapy based on hormone receptor status with nanoparticles comprising taxane

#80 | 2009-12-10 ✅ Patent 8,735,394 granted on 2014-05-27

US20090304805A1

Combinations and modes of administration of therapeutic agents and combination therapy

#81 | 2009-11-26 ✅ Patent 8,415,304 granted on 2013-04-09

US20090291139A1

Sparc and methods of use thereof

#82 | 2009-11-12

US20090280167A1

ENHANCEMENT OF DRUG THERAPY BY MIRNA

#83 | 2009-09-03

US20090220589A1

TREATMENT, DIAGNOSTIC, AND METHOD FOR DISCOVERING ANTAGONIST USING SPARC SPECIFIC MIRNAS

#84 | 2009-08-06 ✅ Patent 7,981,445 granted on 2011-07-19

US20090196933A1

Compositions and methods for preparation of poorly water soluble drugs with increased stability

#85 | 2009-04-16 ✅ Patent 7,758,891 granted on 2010-07-20

US20090098210A1

Combinations and modes of administration of therapeutic agents and combination therapy

#86 | 2008-09-25 ✅ Patent 7,816,346 granted on 2010-10-19

US20080234246A1

Analogs of ansamycin and pharmaceutical compositions thereof

#87 | 2008-07-24 ✅ Patent 7,858,782 granted on 2010-12-28

US20080176853A1

Triazine derivatives and their therapeutical applications

#88 | 2008-07-10

US20080166389A1

Compositions and methods for treatment of hyperplasia

#89 | 2008-07-03

US20080160095A1

Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof

#90 | 2008-06-26

US20080153739A1

COMPOSITIONS AND METHODS FOR TREATMENT OF HYPERPLASIA

#91 | 2008-06-26

US20080153738A1

COMPOSITIONS AND METHODS FOR TREATMENT OF HYPERPLASIA

#92 | 2008-06-19 ✅ Patent 7,799,954 granted on 2010-09-21

US20080146586A1

Dicarbonyl derivatives and methods of use

#93 | 2008-03-13 ✅ Patent 7,780,984 granted on 2010-08-24

US20080063724A1

Methods and compositions for treating proliferative diseases

#94 | 2007-08-16 ✅ Patent 7,674,816 granted on 2010-03-09

US20070191463A1

Substituted melatonin derivatives, process for their preparation, and methods of use

#95 | 2007-07-12 ✅ Patent 7,700,612 granted on 2010-04-20

US20070161668A1

Di-ester prodrugs of camptothecin, process for their preparation and their therapeutical applications

#96 | 2007-05-24 ✅ Patent 7,771,751 granted on 2010-08-10

US20070117744A1

Compositions comprising poorly water soluble pharmaceutical agents and antimicrobial agents

#97 | 2007-05-24 ✅ Patent 8,420,603 granted on 2013-04-16

US20070117133A1

SPARC and methods of use thereof

#98 | 2007-05-24 ✅ Patent 8,257,733 granted on 2012-09-04

US20070116774A1

Methods and compositions for treating proliferative diseases

#99 | 2007-04-26 ✅ Patent 8,853,260 granted on 2014-10-07

US20070093547A1

Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof

#100 | 2007-04-19 ✅ Patent 8,137,684 granted on 2012-03-20

US20070087022A1